| Obesity and Breast Cancer |
| Cancer Journal - Breast Cancer |
|
Obesity and Breast Cancer: The Roles of Peroxisome Proliferator-Activated Receptor-gamma and Plasminogen Activator Inhibitor-1. PPAR Res. 2009;2009:345320 Authors: Carter JC, Church FC Breast cancer is the most prominent cancer among females in the United States. There are a number of risk factors associated with development of breast cancer, including consumption of a high-fat diet and obesity. Plasminogen activator inhibitor-1 (PAI-1) is a cytokine upregulated in obesity whose expression is correlated with a poor prognosis in breast cancer. As a key mediator of adipogenesis and regulator of adipokine production, peroxisome proliferator-activated receptor-gamma (PPAR-gamma) is involved in PAI-1 expression from adipose tissue. We summarize the current knowledge linking PPAR-gamma and PAI-1 expression to high-fat diet and obesity in the risk of breast cancer. PMID: 19672469 [PubMed - in process] Read more: pubmed: breast cancer |
Medical Index Tag's
- asbestosis mesothelioma
- cancer
- Cancer Journal
- cervical cancer
- cervical cancer prevention
- cervical cancer screening
- endometrial cancer
- endometrial cancer chemotherapy
- endometrial cancer diagnosis
- endometrial cancer prognosis
- endometrial cancer treatment
- Free Journal
- Malignant mesothelioma
- mesothelioma
- mesothelioma prognosis
- mesothelioma risk
- mesothelioma treatment
- mesothelioma tumor
- metastatic endometrial cancer
- metastatic mesothelioma
- oncology
- Oncology Journal
- pancreas cancer
- pancreatic cancer chemotherapy
- pancreatic cancer drugs
- pancreatic cancer symptoms
- pancreatic cancer treatment
- peritoneal mesothelioma
- pleural mesothelioma
- sarcomatoid mesothelioma


